Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2003
05/07/2003EP1307483A2 Iapl-3 a protein inhibitor of apoptosis proteins
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307221A2 Modified sialic acid vaccines
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1218396A4 Antibodies specific for fullerenes
05/07/2003EP1206576A4 Novel kinases and uses thereof
05/07/2003EP1183390A4 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
05/07/2003EP0877798B1 Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
05/07/2003EP0853633B1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
05/07/2003EP0785993B1 Monoclonal antibodies to thymidine kinase isozymes
05/07/2003EP0683234B1 Antibody against beta-amyloid or their derivative and use thereof
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416432A Use of CD25 binding molecules in triatment of inflammatory diseases of gastro-intestinal tract
05/07/2003CN1107871C Marking of products to establish identity and source testing box and products
05/07/2003CA2405849A1 Reagents for the simultaneous detection of hcv core antigens and antibodies
05/06/2003US6559359 Plant extression vector for use as efficient gene transfer tool in genetic engineering
05/06/2003US6559288 Ninjurin
05/06/2003US6559286 Antibodies for use in the diagnosis and treatment of cancer
05/06/2003US6558950 Nucleotide sequences coding polypeptide for use in the treatment of programed cell death defects
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558919 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infections
05/06/2003US6558918 Nucleic acid that encode a cell growth regulatory protein
05/06/2003US6558913 Detection of preferential genotype in humans; obtain sample, incubate with probe, evaluate for homo/heterozygosity, evaluate for blood disorder
05/06/2003US6558912 Screening for modulators of apoptosis; obtain cells containing apoptosis polypeptide, incubate with binding protein, expose to modulator, monitor concentration of bound protein in presence of modulator, compare to control
05/06/2003US6558903 Kinases and uses thereof
05/06/2003US6558898 Antibody for use in the treatment of viral diseases
05/06/2003US6558677 Native outer membrane vesicles having outer membrane proteins and lipopolysaccharides from neisseria genetically altered so that neisseria is unable to synthesize sialic acid
05/06/2003US6558676 Immunizing mammal with noninfectious material and isolating antibodies produced
05/06/2003US6558675 Mutant human hepatitis B viral strain and uses thereof
05/06/2003US6558672 Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/06/2003US6558668 Methods for detection and treatment of neural cancers
05/06/2003US6558661 Inhibiting binding of interferon-gamma to its native receptor
05/06/2003CA2199830C Expression and export technology of proteins as immunofusins
05/06/2003CA2153165C Recombinant anti-hiv antibody and process for preparing the same
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/06/2003CA2106955C Product and method for improving keratinocyte adhesion to the dermis
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2078364C A process for the fermentative preparation of amino acids
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
05/02/2003EP1306095A2 Methods and compositions for targeting the vasculature of solid tumors
05/02/2003EP1305636A2 Screening method
05/02/2003EP1305625A1 Method for immuno-detection of epitopes
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305425A2 Drug metabolizing enzymes
05/02/2003EP1305423A2 Enhancement of industrial production by increasing substrate transport
05/02/2003EP1305422A2 2,5-dkg permeases
05/02/2003EP1305421A2 Enhanced 2-keto-l-gulonic acid production
05/02/2003EP1305418A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
05/02/2003EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
05/02/2003EP1305416A2 Identification of a novel glutamine transporter
05/02/2003EP1305415A1 Protein inhibitor of apoptosis proteins
05/02/2003EP1305413A1 Therapeutic compounds
05/02/2003EP1305412A2 Anthozoa derived chromo/fluoroproteins and methods for using the same
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305402A1 Lipo-viro-particle complexes, preparation method and uses
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP1305339A2 3d model of an fc epsilon receptor alpha chain-ige fc region complex
05/02/2003EP1305336A2 Therapeutic anti-melanoma compounds
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305045A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications
05/02/2003EP1109564A4 Method for removal of hiv and other viruses from blood
05/02/2003EP1075488B1 Protein purification by ion exchange chromatography
05/02/2003EP0986396A4 Prion protein modulator factor (ppmf) and prion resistant animals
05/02/2003EP0948544B1 Monovalent antibody fragments
05/02/2003EP0929578B1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
05/02/2003EP0769964B1 Cck antibodies used to improve feed efficiency
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/02/2003EP0592521B1 Marrow-derived human mesenchymal stem cells and monoclonal antibodies specific for said cells
05/01/2003WO2003035892A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
05/01/2003WO2003035887A1 Selection of cells expressing heteromeric polypeptides
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035872A1 Human and mammalian stem cell-derived neuronal survival polypeptides
05/01/2003WO2003035848A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035835A2 Glycoprotein compositions
05/01/2003WO2003035696A2 Humanized antibodies against icam-1, their production and uses
05/01/2003WO2003035695A2 Agents that activate or inhibit toll-like receptor 9
05/01/2003WO2003035694A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035682A2 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035680A1 Infectious salmon anaemia virus vaccine
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035676A1 Groel chimeric protein and vaccine
05/01/2003WO2003035048A2 Methods for the treatment of osteoarthritis and compositions thereof
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034982A2 Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
05/01/2003WO2003034977A2 Combination therapy for treating disease
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002094124A3 Method of increasing uniformity in avians
05/01/2003WO2002089615A3 Anti-ige antibody to treat ocular allergies
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002078741A3 Methods and compositions for modulating the immune system of animals
05/01/2003WO2002078630A3 Tub 3'-variant
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1494